M. Sch�fer-Korting

728 total citations
19 papers, 523 citations indexed

About

M. Sch�fer-Korting is a scholar working on Analytical Chemistry, Pharmacology and Dermatology. According to data from OpenAlex, M. Sch�fer-Korting has authored 19 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Analytical Chemistry, 5 papers in Pharmacology and 5 papers in Dermatology. Recurrent topics in M. Sch�fer-Korting's work include Analytical Methods in Pharmaceuticals (6 papers), Fungal Plant Pathogen Control (4 papers) and Dermatology and Skin Diseases (4 papers). M. Sch�fer-Korting is often cited by papers focused on Analytical Methods in Pharmaceuticals (6 papers), Fungal Plant Pathogen Control (4 papers) and Dermatology and Skin Diseases (4 papers). M. Sch�fer-Korting collaborates with scholars based in Germany and Estonia. M. Sch�fer-Korting's co-authors include Hans Christian Körting, E. Mutschler, H.C. Korting, Otto Braun‐Falco, H.C. Korting, M.-H. Schmid, M. Reiter, Alexander Heiss, Huberta E. Hart and H. Knauf and has published in prestigious journals such as Journal of Molecular Medicine, Naunyn-Schmiedeberg s Archives of Pharmacology and European Journal of Clinical Pharmacology.

In The Last Decade

M. Sch�fer-Korting

19 papers receiving 494 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M. Sch�fer-Korting 160 136 104 82 53 19 523
Katsuyoshi Chiba 217 1.4× 37 0.3× 335 3.2× 251 3.1× 49 0.9× 46 790
Paul A. Lehman 363 2.3× 368 2.7× 206 2.0× 7 0.1× 35 0.7× 40 804
D. Rambhau 55 0.3× 240 1.8× 147 1.4× 5 0.1× 53 1.0× 41 526
Kanchan Kohli 30 0.2× 63 0.5× 111 1.1× 22 0.3× 70 1.3× 21 417
Gholamreza Bahrami 30 0.2× 67 0.5× 132 1.3× 8 0.1× 26 0.5× 23 364
Zhi Lu 24 0.1× 26 0.2× 143 1.4× 21 0.3× 61 1.2× 14 561
Alaa Sirwi 13 0.1× 85 0.6× 244 2.3× 45 0.5× 92 1.7× 34 682
Sharon A.M. Hotchkiss 422 2.6× 194 1.4× 100 1.0× 4 0.0× 40 0.8× 33 930
Jeffrey D. Vassallo 368 2.3× 27 0.2× 170 1.6× 8 0.1× 50 0.9× 16 818
Casey L. Sayre 12 0.1× 63 0.5× 190 1.8× 22 0.3× 82 1.5× 27 590

Countries citing papers authored by M. Sch�fer-Korting

Since Specialization
Citations

This map shows the geographic impact of M. Sch�fer-Korting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Sch�fer-Korting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Sch�fer-Korting more than expected).

Fields of papers citing papers by M. Sch�fer-Korting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Sch�fer-Korting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Sch�fer-Korting. The network helps show where M. Sch�fer-Korting may publish in the future.

Co-authorship network of co-authors of M. Sch�fer-Korting

This figure shows the co-authorship network connecting the top 25 collaborators of M. Sch�fer-Korting. A scholar is included among the top collaborators of M. Sch�fer-Korting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Sch�fer-Korting. M. Sch�fer-Korting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Korting, H.C., et al.. (1995). Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema. European Journal of Clinical Pharmacology. 48(6). 461–5. 31 indexed citations
2.
Sch�fer-Korting, M., et al.. (1994). Liposomal tretinoin for uncomplicated acne vulgaris. Journal of Molecular Medicine. 72(12). 1086–1091. 63 indexed citations
3.
Körting, Hans Christian, et al.. (1993). Influence of topical erythromycin preparations for acne vulgaris on skin surface pH. Journal of Molecular Medicine. 71(8). 644–8. 13 indexed citations
4.
Körting, Hans Christian, et al.. (1993). Anti-inflammatory activity of hamamelis distillate applied topically to the skin. European Journal of Clinical Pharmacology. 44(4). 315–318. 53 indexed citations
5.
Körting, Hans Christian, et al.. (1990). Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. European Journal of Clinical Pharmacology. 39(4). 349–351. 94 indexed citations
6.
Belz, G. G., et al.. (1988). The relationship between pharmacokinetics and pharmacodynamics of enoximone in healthy man. European Journal of Clinical Pharmacology. 35(6). 631–635. 11 indexed citations
7.
Korth, Michael, J. W. Engels, & M. Sch�fer-Korting. (1987). Influence of phosphodiesterase inhibition and of carbachol on inotropic effects of 8-substituted cyclic AMP analogues. Naunyn-Schmiedeberg s Archives of Pharmacology. 335(2). 166–75. 8 indexed citations
8.
Sch�fer-Korting, M., et al.. (1986). Cefodizime penetration into skin suction blister fluid following a single intravenous dose. European Journal of Clinical Pharmacology. 30(3). 295–298. 13 indexed citations
9.
Sch�fer-Korting, M., Hans Christian Körting, & E. Mutschler. (1985). Human plasma and skin blister fluid levels of griseofulvin following a single oral dose. European Journal of Clinical Pharmacology. 29(1). 109–113. 21 indexed citations
10.
Sch�fer-Korting, M., Hans Christian Körting, & E. Mutschler. (1985). Human plasma and skin blister fluid levels of griseofulvin after its repeated administration. European Journal of Clinical Pharmacology. 29(3). 351–354. 11 indexed citations
11.
Sch�fer-Korting, M., et al.. (1985). Pharmacokinetics of carteolol in relation to renal function. European Journal of Clinical Pharmacology. 29(4). 461–465. 6 indexed citations
12.
Sch�fer-Korting, M., et al.. (1984). Pharmacokinetics of nadolol in healthy subjects. European Journal of Clinical Pharmacology. 26(1). 125–127. 11 indexed citations
13.
Wellstein, Anton, D. Palm, Gabriele Wiemer, M. Sch�fer-Korting, & E. Mutschler. (1984). Simple and reliable radioreceptor assay for beta-adrenoceptor antagonists and active metabolites in native human plasma. European Journal of Clinical Pharmacology. 27(5). 545–553. 31 indexed citations
14.
Heiss, Alexander, et al.. (1984). UD-CG 115 ? a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle. Naunyn-Schmiedeberg s Archives of Pharmacology. 325(3). 259–269. 54 indexed citations
15.
Wais, U, et al.. (1983). Pharmacokinetics of hydrochlorothiazide in relation to renal function. European Journal of Clinical Pharmacology. 24(5). 661–665. 39 indexed citations
16.
Sch�fer-Korting, M., et al.. (1982). Does cantharides blister fluid provide access to the peripheral compartment?. European Journal of Clinical Pharmacology. 23(4). 327–330. 16 indexed citations
17.
Sch�fer-Korting, M. & E. Mutschler. (1982). Pharmacokinetics of bendroflumethiazide alone and in combination with propranolol and hydralazine. European Journal of Clinical Pharmacology. 21(4). 315–323. 5 indexed citations
18.
Korting, H.C., et al.. (1981). Determination of 8-methoxypsoralen levels in plasma and skin suction blister fluid by a new sensitive fluorodensitometric method. Archives of Dermatological Research. 272(1-2). 9–20. 15 indexed citations
19.
Sch�fer-Korting, M. & H.C. Korting. (1981). Intraindividual variations of 8-methoxypsoralen plasma levels. Archives of Dermatological Research. 272(1-2). 1–7. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuyoshi Chiba Breakdown of academic impact, for papers by Paul A. Lehman Breakdown of academic impact, for papers by D. Rambhau Breakdown of academic impact, for papers by Kanchan Kohli Breakdown of academic impact, for papers by Gholamreza Bahrami Breakdown of academic impact, for papers by Zhi Lu Breakdown of academic impact, for papers by Alaa Sirwi Breakdown of academic impact, for papers by Sharon A.M. Hotchkiss Breakdown of academic impact, for papers by Jeffrey D. Vassallo Breakdown of academic impact, for papers by Casey L. Sayre
Rankless by CCL
2026